120 related articles for article (PubMed ID: 17409514)
1. Effects of acute renal failure and ganciclovir on the pharmacodynamics of levofloxacin-induced seizures in rats.
Ishiwata Y; Son K; Itoga Y; Yasuhara M
Biol Pharm Bull; 2007 Apr; 30(4):745-50. PubMed ID: 17409514
[TBL] [Abstract][Full Text] [Related]
2. Effect of experimental renal failure on the pharmacodynamics of cefoselis-induced seizures in rats.
Nagata M; Yasuhara M
Biol Pharm Bull; 2001 Sep; 24(9):1049-52. PubMed ID: 11558567
[TBL] [Abstract][Full Text] [Related]
3. Effect of bile duct ligation and unilateral nephrectomy on brain concentration and convulsant potential of the quinolone antibacterial agent levofloxacin in rats.
Akahane K; Ohkawara S; Nomura M; Kato M
Fundam Appl Toxicol; 1996 Feb; 29(2):280-6. PubMed ID: 8742326
[TBL] [Abstract][Full Text] [Related]
4. Lung tissue distribution after intravenous administration of grepafloxacin: comparative study with levofloxacin.
Yamamoto H; Koizumi T; Hirota M; Kaneki T; Ogasawara H; Yamazaki Y; Fujimoto K; Kubo K
Jpn J Pharmacol; 2002 Jan; 88(1):63-8. PubMed ID: 11855679
[TBL] [Abstract][Full Text] [Related]
5. Interaction between levofloxacin and vancomycin in rats--study of serum and organ levels.
Mori H; Nakajima T; Nakayama A; Yamori M; Izushi F; Gomita Y
Chemotherapy; 1998; 44(3):181-9. PubMed ID: 9612608
[TBL] [Abstract][Full Text] [Related]
6. Effect of isoniazid on the pharmacodynamics of cefazolin-induced seizures in rats.
Ishiwata Y; Nagata M; Yasuhara M
Drug Metab Pharmacokinet; 2005 Apr; 20(2):117-20. PubMed ID: 15855723
[TBL] [Abstract][Full Text] [Related]
7. Effect of experimental renal failure and hypotonic hyponatremia on the pharmacodynamics of cefazolin-induced seizures in rats.
Nagata M; Fujichika T; Yasuhara M
Pharm Res; 2003 Jun; 20(6):937-42. PubMed ID: 12817901
[TBL] [Abstract][Full Text] [Related]
8. Plasma and CSF pharmacokinetics of ganciclovir in nonhuman primates.
Serabe BM; Murry DJ; Dauser R; Nuchtern J; Durfee J; McGuffey L; Berg S; Blaney SM
Cancer Chemother Pharmacol; 1999; 43(5):415-8. PubMed ID: 10100598
[TBL] [Abstract][Full Text] [Related]
9. Population pharmacokinetics of oral levofloxacin 500 mg once-daily dosage in community-acquired lower respiratory tract infections: results of a prospective multicenter study in China.
Zhang J; Xu JF; Liu YB; Xiao ZK; Huang JA; Si B; Sun SH; Xia QM; Wu XJ; Cao GY; Shi YG; Zhang YY
J Infect Chemother; 2009 Oct; 15(5):293-300. PubMed ID: 19856067
[TBL] [Abstract][Full Text] [Related]
10. Effects of antibacterial agents, levofloxacin and clarithromycin, on aquatic organisms.
Yamashita N; Yasojima M; Nakada N; Miyajima K; Komori K; Suzuki Y; Tanaka H
Water Sci Technol; 2006; 53(11):65-72. PubMed ID: 16862775
[TBL] [Abstract][Full Text] [Related]
11. Multiple drug transporters contribute to the brain transfer of levofloxacin.
Cen Y; Shan Y; Zhao J; Xu X; Nie Z; Zhang J
CNS Neurosci Ther; 2023 Jan; 29(1):445-457. PubMed ID: 36253925
[TBL] [Abstract][Full Text] [Related]
12. Fluoroquinolone concentrations in plasma, urine, and bile after oral administration in rats with renal failure: useful technique for long-term bile collection.
Mizuta K; Hishikawa S; Hirota M; Miyamoto G; Fujimura A; Hakamata Y; Kobayashi E
J Med; 2001; 32(5-6):311-20. PubMed ID: 11958277
[TBL] [Abstract][Full Text] [Related]
13. [In vitro activities of levofloxacin and other antibiotics against fresh clinical isolates].
Matsuzaki K; Koyama H; Chiba A; Omika K; Harada S; Sato Y; Hasegawa M; Kobayashi I; Kaneko A; Sasaki J
Jpn J Antibiot; 1999 Sep; 52(9):571-84. PubMed ID: 10746192
[TBL] [Abstract][Full Text] [Related]
14. [Therapeutic efficacy of levofloxacin against a model of replicable Legionella pneumophila lung infection in DBA/2 mice].
Kashimoto Y; Kurosaka Y; Karibe Y; Uoyama S; Fujikawa K; Namba K; Otani T; Yamaguchi K
Jpn J Antibiot; 2009 Oct; 62(5):452-9. PubMed ID: 20055122
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy and safety of levofloxacin in patients with nursing and healthcare-associated pneumonia].
Yamasaki K; Yatera K; Kawanami T; Sasahara Y; Hata R; Uchimura K; Tachiwada T; Naito K; Kato K; Takaki T; Shimabukuro I; Shiraishi T; Oda K; Hara K; Chojin Y; Suzuki Y; Akata K; Ogoshi T; Tokuyama S; Inoue N; Noguchi S; Nishida C; Orihashi T; Yoshida Y; Kawanami Y; Taura Y; Ishimoto H; Obata H; Awaya Y; Tsuda T; Yoshii C; Mukae H
Jpn J Antibiot; 2014 Feb; 67(1):23-32. PubMed ID: 24809206
[TBL] [Abstract][Full Text] [Related]
16. Involvement of inhibitory and excitatory neurotransmitters in levofloxacin- and ciprofloxacin-induced convulsions in mice.
Akahane K; Kato M; Takayama S
Antimicrob Agents Chemother; 1993 Sep; 37(9):1764-70. PubMed ID: 7902066
[TBL] [Abstract][Full Text] [Related]
17. Population pharmacokinetics of levofloxacin in Korean patients.
Kiem S; Ryu SM; Lee YM; Schentag JJ; Kim YW; Kim HK; Jang HJ; Joo YD; Jin K; Shin JG; Ghim JL
J Chemother; 2016 Aug; 28(4):308-13. PubMed ID: 25976699
[TBL] [Abstract][Full Text] [Related]
18. Attenuated inhibition by levofloxacin, l-isomer of ofloxacin, on GABA response in the dissociated rat hippocampal neurons.
Imanishi T; Akahane K; Akaike N
Neurosci Lett; 1995 Jun; 193(2):81-4. PubMed ID: 7478164
[TBL] [Abstract][Full Text] [Related]
19. Effect of renal failure on neurotoxicity of ranitidine in rats.
Nakada Y; Yamamoto K; Kawakami J; Sawada Y; Iga T
Biol Pharm Bull; 1996 Feb; 19(2):323-5. PubMed ID: 8850334
[TBL] [Abstract][Full Text] [Related]
20. Levofloxacin pharmacokinetics and pharmacodynamics in patients with severe burn injury.
Kiser TH; Hoody DW; Obritsch MD; Wegzyn CO; Bauling PC; Fish DN
Antimicrob Agents Chemother; 2006 Jun; 50(6):1937-45. PubMed ID: 16723549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
